The largest database of trusted experimental protocols

11 protocols using cd25 apc

1

In Vitro Assessment of CAR-T Cell Efficacy

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro studies with CAR-T cells (CD19-CD28z and CD19-BBz) were performed for the assessment of efficacy and cytotoxic capacity. For that purpose, anti-CD19-expressing CAR-T cells and CD19-expressing RAJI cells were cultured for 24 h, 7 days, and 14 days (CAR-T: RAJI; 1:1, 5:1, 10:1). Anti-cancer profiling studies on days 14 and 21 were analyzed using CD3-PC7 (Beckman Coulter, 6607100), CD4-APC-A700 (Beckman Coulter, B10824), CD8-PC5.5 (Beckman Coulter, B21205), EGFR-A488 (R&D Systems, FAB10951G), CD19-ECD (Beckman Coulter, A07770), CD25-APC (Miltenyi Biotech, 130-113-284), and CD107a (LAMP-1) -PE (Miltenyi Biotech, 130-111-621) by Cytoflex Flow Cytometer analysis. In the co-culture experiments, the death of CD19+ RAJI cells after 48 h and the CD25 activation (IL2RA, IL-2 receptor alpha chain) and CD107a (marker for degranulation of lymphocytes) cytotoxic de-granulation biomarkers of CAR-T cells and control T cells in CD3+ T cells were analyzed by flow cytometry. Survival analysis of CAR-T cells was performed to control the cell viability of RAJI cells and CAR-T cells. Trypan blue (Biological Industries, #03-102-1B) was applied to identify and count surviving cells. Cell counting and viability analysis were performed with the BIO-RAD TC20 Automated Cell Counter.
+ Open protocol
+ Expand
2

Immune Cell Profiles in Pregnancy and Multiple Sclerosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ and CD8+ T lymphocytes, Treg, NKbright and M2 monocytes were evaluated in blood specimen of HC and MS patients at different trimester of pregnancy. In addition, the same populations were analyzed in decidual tissues. The analyses were performed by a biologist blinded to the clinical data.
Non-specific sites of 3 × 106 cells were blocked with rabbit immunoglobulins G (IgG, Sigma-Aldrich), and cells were then incubated with fluorochrome-conjugated monoclonal Ab (mAb) and isotype–matched negative controls for 10 min at 4°C. The following anti-human mAbs were used: CD163 Phycoerythrin (PE) and CD14 Fluorescein isothiocyanate (FITC) for M2 monocytes, CD3 allophycocyanin (APC)-Vio770, CD16 FITC and CD56 APC for NK cells, CD3 APC-Vio770, CD4 PE-Vio770 and CD8 FITC for T cells, CD4 PE-Vio770, CD25 APC, and CD127 FITC for Treg (Miltenyi Biotec, Bergisch Gladbach, Germany). Living cells identified by propidium iodide (Sigma-Aldrich) exclusion were gated according to their light-scatter properties to exclude cell debris. Samples were analyzed using a CyAn ADP, running Summit 4.3 software (Beckman Coulter, Brea, CA, USA). The gating strategy is shown in the Figure 1.
+ Open protocol
+ Expand
3

Multicolor Flow Cytometry of PBMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
We isolated peripheral blood mononuclear cells (PBMC) from peripheral blood by Ficoll gradient and we stored them in liquid nitrogen for batched analysis. For multicolor flow cytometry analyses, we used the following monoclonal antibodies: from Becton Dickinson (BD, Franklin Lakes, NJ), CD3-FITC, CD3-PerCP-Cy5.5, CD4-APC-Cy7, CD8-BV510, CD45RO-FITC, CD45RA-APC, CD45RA-APC-Cy7, CD71-PE, IgD-PerCP-Cy5.5, CD25-APC-Cy7, CD138-BV421, CCR4-PE, CD27-PE, CD95-BV421, CD28-BV421, TIM3-BV421, CCR6-BV421, CCR7-AF700, CXCR3-PE, IL-2-PE, IL-17-BV786, and IFN-γ-PE-Cy7; from Biolegend (San Diego, CA), CD19-BV510, CD56-FITC, CD27-APC, CD127-FITC, CD57-PerCp-Cy5.5, PD-1-APC-Cy7, CXCR5-FITC, LAG3-APC, IL-10-PerCP-Cy5.5, and TNF-α-FITC. From eBioscience (San Diego, CA), CD4-PE-Cy7, CD21-PE, and CD24-APC-Cy7 were used. From Miltenyi Biotec (Auburn, CA), CD25-APC and anti-KLRG1-PE were used. From Beckman Coulter (Indianapolis, IN), CD38-PE-Cy7 was used.
We performed intracellular staining for IL-2, IL-4, IL-17, IFN-g, and TNF-a together with extracellular markers for CD4+, CD8+, and CD19+. Cells were fixed and permeabilized using Intracellular Fixation and Permeabilization Buffer Set (eBioscience) according to the manufacturer’s instructions.
Data were acquired (> 1 × 106 events) on a 3-laser FACSLyric flow cytometer (BD Biosciences) and analyzed with FlowJo® software.
+ Open protocol
+ Expand
4

Flow Cytometry Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies and reagents used for flow cytometry were as follows: CD11c-BV421 (585452), MHCII-fluorescein isothiocyanate (FITC) (553623), 7-aminoactinomycin D (7AAD) (51-68981E), CD69-FITC (553236), CD11c-phycoerythrin (PE) (557401), and anti-mouse CD16/CD32 (Fc block) (553142) provided by Becton Dickinson (BD); CD40-allophycocyanin (APC) (20-8050-U025), CD44-V450 (75-0441-U025), CD4-PECy7 (60-0041-U100), CD45.1-PerCPCy5 (65-0453-U500), CD3-FITC (35-0031-U500), CD8-PECy7 (60-0081), and Ghost Red 780 Viability Dye (13-0865-T100) from Tonbo Biosciences; CD4-FITC (130-109-498), CD62L-PerCP-Vio700 (130-107-072), CD25-APC (130-109-052), CD4-PerCPCy5.5 (130-109-497), and CD11c-FITC (130-102-466) provided by Miltenyi; CCR7-PE (120105) and TCRβ-APCCy7 (109220) from BioLegend; and AbC RH capture beads (A10389) and LIVE/DEAD Fixable Yellow Dead Cell Stain (L34968) from Invitrogen. In addition, cell dyes 5-(and-6)-(((4-chloromethyl)benzoyl)amino)tetramethylrhodamine (CMTMR) (C2927) and carboxyfluorescein diacetate succinimidyl ester (CFSE) (C34554) were obtained from Thermo Fisher Scientific, and recombinant murine chemokine MIP-3β (CCL19) (250-27B) was provided by Peprotech.
+ Open protocol
+ Expand
5

Quantifying Immune Cell Subsets in Spleen

Check if the same lab product or an alternative is used in the 5 most similar protocols
To test the cell count of CD3+CD25+ cells,CD3+CD8+ cells, CD4+CD25+ Foxp3+Tregs, CD11c+MHC-II+ DCs in the spleen, splenic single-cell suspensions were prepared with the final concentration of 1 × 107/ml before immunofluorescent staining. Fluorescent antibodies, including CD3ε-FITC, CD8a-PerCP, CD4-PE, CD25-APC, Foxp3+-FITC, CD11c-PE, MHC-II-FITC (Miltenyi Biotec, Germany), were added to the suspensions respectively. After incubation for 10mins, cells were washed in PBS, followed by centrifuging for 10 mins and fixation in 1% polyoxymethylene for more than 2 hours. Cells were analyzed using flow cytometry.
+ Open protocol
+ Expand
6

Regulatory T-Cell Levels in Autoimmune Diseases

Check if the same lab product or an alternative is used in the 5 most similar protocols
Regulatory T-cell levels were evaluated in 29 HTE, 17 HTI, 22 MS, 12 MS + HT, and 33 HC. After gentle thawing at 37°C, PBMCs were immediately added to 5-mL RPMI 1640 (Thermo Fisher Scientific), supplemented with 10% FBS (Thermo Fisher Scientific) and centrifuged to remove DMSO (Sigma-Aldrich). Samples were resuspended in RPMI 1640 medium supplemented with 10% heat-inactivated FBS and counted for flow-cytometry experiments.
For Treg evaluation, PBMCs were incubated for 5 min at 4°C with rabbit immunoglobulins G (IgG, Sigma-Aldrich) to block non-specific sites and then for 10 min at 4°C with fluorochrome-conjugated monoclonal Ab (mAb) or isotype-matched negative controls. For Treg determination the following antihuman mAbs were used: CD4 PE-Vio770, CD25 APC, and CD127 FITC (Miltenyi Biotec, Bergisch Gladbach, Germany). Living cells identified by propidium iodide (Sigma-Aldrich) exclusion were gated according to their light-scatter properties to exclude cell debris. Samples were analyzed using a CyAn ADP, running Summit 4.3 software (Beckman Coulter, Brea, CA, USA).
+ Open protocol
+ Expand
7

Isolation of Human Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood mononuclear cells (PBMCs) were isolated from the blood of healthy donors and uveitis patients using a Ficoll gradient centrifugation protocol. Untouched naïve and memory CD4+ T cells were isolated based on magnetic depletion protocols (Mitenyi Biotec) or by flow cytometry (BD Influx). Monocytes or lymphocyte fractions were obtained either by elutriation from the NIH Blood Bank, by magnetic bead isolation (Mitenyi Biotec) or by flow cytometric sorting of donor PBMCs. Subsets of monocytes were further purified by flow cytometry (BDFACSAria II or BD Influx) based on CD14 and CD16 staining.
CD4+CD25+ T regulatory cells (Treg) from healthy donors were isolated using the CD4+CD25+CD127dim/− regulatory T Cell isolation kit II (Miltenyi Biotech) according to the manufacturer’s instructions. Labeled CD4+CD25+ T cells were obtained by passing cells through MACS and MS Separation columns twice (Miltenyi Biotech). Both the positive and negative fractions were assessed for purity using CD4-APC-Cy7 (eBiosciences) CD25-APC (Miltenyi Biotech), FOXP3-PE (ebiosciences), CTLA-4-BV421 (BD Biosciences) and CD127-BV510 (eBiosciences).
+ Open protocol
+ Expand
8

Expansion of Regulatory T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed using a FACSCalibur TM flow cytometer (BD, USA) equipped with CellQuest Pro Software. Isolated cells were identified based on the forward scatter and side scatter. Briefly, cells were washed and stained with CD4-FITC, CD25-APC, and CD127-PE (Miltenyi Biotech, Germany) for 30 min at 4°C. Appropriate isotype control antibodies were used for each sample to assign gates and analysis carried out, using the FlowJo software (TreeStar Inc, OR, USA).
Treg Expansion 1 × 10 5 isolated Tregs were cultured in 100 μL TexMACS TM good manufacturing practice (GMP) cell culture medium (Miltenyi Biotech, Germany) supplemented with 10% FBS (PAN-Biotech, Germany), 100 nM rapamycin (Rapamune ® , Wyeth, USA), 500 IU/mL human recombinant IL-2 and containing 50 IU/mL pen-strep (PAN-Biotech, Germany), 1 mM sodium pyruvate (Sigma-Aldrich, USA), 25 mM HEPES (Sigma-Aldrich, USA), and activated with anti-CD3/CD28-coated beads (1:4 cell: bead ratio, Treg Expansion Kit; Miltenyi Biotec) in 48 well-plate (Sigma-Aldrich, USA) for 5 days [2, 21] . Confluent wells were split into new plates, and 100 IU/mL rIL-2 was added at day 1 and replenished every second day.
+ Open protocol
+ Expand
9

Dornase alfa and MgSO4 Effects on PBMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three healthy adult blood was obtained from Acibadem Labcell Cellular Therapy Laboratory.
Following the isolation of peripheral mononuclear cells (PBMC) by overlaying blood on Ficollpaque plus (GE Healthcare), the serially diluted (300 U/mL, 100 U/mL, 30 U/mL, 10 U/mL, 3 U/mL) Dornase alfa (Pulmozyme®, Roche, USA) and 420 g/mL MgSO 4 (Magnesium Sulphate 15% Onfarma, TR) were incubated with the PBMCs for 48hr in T cell medium (6% Human AB Serum and 1% Pen/Strep, Texmacs medium). Immune cell subtypes and their activation levels were determined by Miltenyi MACSQuant flow cytometry analysis using CD3-PE, CD19-PE.cy7, CD56-FITC, CD4-Viogreen, CD8-Vioblue, CD25-APC and CD107a-PE.cy5.5 (Miltenyi).
+ Open protocol
+ Expand
10

Comprehensive Immune Cell Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
MACSQuant Analyzer 10 (Miltenyi Biotec, Bergisch Gladbach, Germany) was used for flow cytometry analysis. To measure cell surface markers, Tregs or PBMCs were stained with CD4-PerCp, CD25-PE, CD127-Vio770, CD152-APC, CD39-FITC and CD223-APC antibodies (all from Miltenyi Biotec, Bergisch Gladbach, Germany), according to the manufacturer's protocol. To measure FoxP3 and Helios protein content, PBMCs or eTregs were treated with CD4-FITC, CD25-APC (all from Miltenyi Biotec, Bergisch Gladbach, Germany), FoxP3-PE or Helios-PE antibodies (BD Pharmingen, San Diego, CA, USA) followed by flow cytometry analysis according to the manufacturer's protocol. Mean fluorescence intensity (MFI) was used to determine intracellular protein expression of FoxP3 and Helios. To measure cell proliferation, isolated CD4 + cells were labeled with the vital dye CFSE (5-(and 6-)carboxyfluorescein diacetate succinimidyl ester, eBioscience Inc., San Diego, CA, USA) and analyzed by flow cytometry every 24 h during expansion. The proportion of proliferated cells was determined as the proportion of cells with reduced CFSE signal. Alternatively, a CD4 + CD25 + regulatory T cell isolation kit, human (Miltenyi Biotec), was used to obtain pTregs as a comparison group for functional tests (FOXP3 promoter methylation, gene expression and in vitro immunosuppression assays).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!